The top 100 stock
market authors
selected for publication
market authors
selected for publication
Novo Nordisk A/S (NVO) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Novo Nordisk A/S (NVO) by latest | most commented
- Big Pharma: Where's the Risk Management?
- FDA Calendar Updates: Novo Nordisk, Eisai, Acura, King and Myriad Pharma
- Preview from Europe: Stocks End Quarter with a Whimper
- European Stocks in the News
- How Bad Is Sanofi's Safety Scare?
- ADA Meeting 2009: Novel Diabetes Therapies Presented
- These European Nations Are in Worse Shape than the U.S.
- The 30 Best U.S. Traded International Dividend Stocks
- Emisphere: Improving Drug Delivery
- What's in Store for Amylin and Biogen Idec's Shareholder Meetings?
- Early Filing for Byetta: Will It Become a Blockbuster?
- FDA Calendar Updates: Diabetes
- Amylin's Pullback Is Unjustified
- FDA Calendar Updates: Santarus, Cephalon, AstraZeneca, Dendreon, Gilead, Novo Nordisk
- 15 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week
- Which Diabetes Drugs Will Win Out?
- Novo Nordisk Short Interest Increases 500% in March
- Merck's Jumpin' Januvia Gets a Reprieve
- Updates to FDA and Clinical Trial Calendars
- Expect More REITs Stock Dividends
- Will 2009 Be a Year for Pharma Currency Speculators?
- Healthcare Reform, M&A Likely to Focus on Preventative Medicine
- Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
- New Scandinavian Nordic Region Index
- New Index of Preventive Medicine Companies
- Nine Pharma Predictions for 2009
- China Biopharma News Back in the Spotlight
- Big Pharma Steps Up China Investment
- What Are Some of the Best Hedge Fund Managers Doing?
- Novo Nordisk: Approval of New Diabetes Drug Is Further Postponed
- China Biotech in Review: Earnings Week
- Novo Nordisk Expands R&D Presence in China with New Manufacturing Plant
- Bullish Outlook for Preventive Medicine Companies Reflected in New ETF
- The Market Is Weak - Fast Money Recap (9/8/08)
- AstraZeneca Gives FluMist Spray a Shot in the Arm
- Four Drug Companies Vying for Diabetes Patients
- NordiCaps Regional Stock Index: Tracking Scandinavia's Finest
- Credit Suisse Healthier 15: Investors Get the Skinny on Fat Fighters
- Diabetes Stocks Remain Healthy
- Is Lilly and Amylin's Byetta Better?
- ADA's 68th Scientific Sessions: A New Look at Insulin Therapy
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
David Fry
-
2
Bill Gross
-
3
Philip Davis
-
4
Tyler Durden
-
5
TraderMark
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
